Name | Number of supported studies | Average coverage | |
---|---|---|---|
non-classical monocyte | 4 studies | 24% ± 7% | |
astrocyte | 4 studies | 23% ± 10% | |
endothelial cell | 3 studies | 19% ± 4% |
Insufficient scRNA-seq data for expression of CHST7 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 97% | 582.64 | 2564 / 2642 | 100% | 24.18 | 704 / 705 |
thymus | 100% | 684.68 | 651 / 653 | 96% | 11.18 | 580 / 605 |
adrenal gland | 92% | 338.28 | 238 / 258 | 92% | 38.95 | 211 / 230 |
lung | 97% | 403.22 | 559 / 578 | 85% | 12.50 | 987 / 1155 |
uterus | 100% | 659.75 | 170 / 170 | 81% | 8.09 | 373 / 459 |
prostate | 96% | 474.17 | 236 / 245 | 84% | 4.48 | 424 / 502 |
esophagus | 91% | 387.26 | 1319 / 1445 | 83% | 11.90 | 152 / 183 |
breast | 100% | 836.51 | 459 / 459 | 69% | 3.81 | 775 / 1118 |
liver | 92% | 410.97 | 207 / 226 | 68% | 7.00 | 275 / 406 |
bladder | 100% | 489.81 | 21 / 21 | 57% | 4.61 | 288 / 504 |
kidney | 82% | 393.51 | 73 / 89 | 74% | 7.30 | 670 / 901 |
intestine | 96% | 411.94 | 925 / 966 | 53% | 3.40 | 280 / 527 |
stomach | 83% | 288.28 | 297 / 359 | 65% | 4.61 | 187 / 286 |
ovary | 100% | 3599.39 | 180 / 180 | 47% | 2.79 | 202 / 430 |
skin | 96% | 669.18 | 1728 / 1809 | 41% | 3.11 | 195 / 472 |
pancreas | 40% | 83.79 | 132 / 328 | 87% | 7.18 | 155 / 178 |
adipose | 100% | 1265.25 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 1105.00 | 241 / 241 | 0% | 0 | 0 / 0 |
heart | 100% | 1227.18 | 857 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 636.30 | 1325 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 11.01 | 44 / 45 |
lymph node | 0% | 0 | 0 / 0 | 90% | 11.91 | 26 / 29 |
peripheral blood | 85% | 486.12 | 790 / 929 | 0% | 0 | 0 / 0 |
muscle | 82% | 266.99 | 657 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 4% | 0.23 | 3 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006044 | Biological process | N-acetylglucosamine metabolic process |
GO_0030206 | Biological process | chondroitin sulfate biosynthetic process |
GO_0005976 | Biological process | polysaccharide metabolic process |
GO_0006790 | Biological process | sulfur compound metabolic process |
GO_0005802 | Cellular component | trans-Golgi network |
GO_0000139 | Cellular component | Golgi membrane |
GO_0016020 | Cellular component | membrane |
GO_0008459 | Molecular function | chondroitin 6-sulfotransferase activity |
GO_0001517 | Molecular function | N-acetylglucosamine 6-O-sulfotransferase activity |
Gene name | CHST7 |
Protein name | Carbohydrate sulfotransferase 7 (EC 2.8.2.-) (EC 2.8.2.17) (Chondroitin 6-sulfotransferase 2) (C6ST-2) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 5) (GST-5) (N-acetylglucosamine 6-O-sulfotransferase 4) (GlcNAc6ST-4) (Gn6st-4) Alternative protein CHST7 |
Synonyms | |
Description | FUNCTION: Sulfotransferase that utilizes 3'-phospho-5'-adenylyl sulfate (PAPS) as sulfonate donor to catalyze the transfer of sulfate to position 6 of non-reducing N-acetylglucosamine (GlcNAc) residues. Preferentially acts on mannose-linked GlcNAc. Also able to catalyze the transfer of sulfate to position 6 of the N-acetylgalactosamine (GalNAc) residue of chondroitin. Also acts on core 2 mucin-type oligosaccharide and N-acetyllactosamine oligomer with a lower efficiency. Has weak or no activity toward keratan sulfate and oligosaccharides containing the Galbeta1-4GlcNAc. Catalyzes 6-O-sulfation of beta-benzyl GlcNAc but not alpha- or beta-benzyl GalNAc. . |
Accessions | ENST00000276055.4 Q9NS84 L8EA50 |